Loading
BT
Biora Therapeutics, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 14 Nov 2022.
Biora Therapeutics, Inc.: what insiders have been doing
Biora Therapeutics, Inc. belongs to the Health Care sector. Filings by its managers are published through SEC (Form 4). No insider at Biora Therapeutics, Inc. has published a filing in the past twelve months. The most recent one dates from 16 August 2024.
Since 2021, the database holds 3 purchases and 1 sale by insiders of the company.
For comparison within the same sector, see the insider buying recorded at Anixa Biosciences Inc and Vivos Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
83
Thresholds
n/a
Buy Volume
€17M
3 ops. · all time
Sell Volume
€4,470
1 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Last declaration on 16 August 2024
Declarations83 total
27,830 shares@ US$0.6710.8% of flowCommon StockSEC:0000950170-24-098046:0
26,629 shares@ US$0.6711.9% of flowCommon StockSEC:0000950170-24-098050:0
70,883 shares@ US$0.679.3% of flowCommon StockSEC:0000950170-24-098048:0
12,500 shares0Common StockSEC:0000950170-24-069928:0
12,500 shares0Common StockSEC:0000950170-24-069927:0
12,500 shares0Common StockSEC:0000950170-24-069926:0
12,500 shares0Common StockSEC:0000950170-24-069929:0
819,000 shares0Common StockSEC:0000950170-24-015858:0
230,000 shares0Common StockSEC:0000950170-24-015859:0
325,000 shares0Common StockSEC:0000950170-24-015862:0
9,235,281 sharesCommon StockSEC:0000899243-23-019263:0
36,183 shares@ US$3.1476.3% of flowCommon StockSEC:0000950170-23-043230:0
117,881 shares@ US$3.1473.3% of flowCommon StockSEC:0000950170-23-043221:0
40,022 shares@ US$3.1473.5% of flowCommon StockSEC:0000950170-23-043225:0
12,500 shares0Common StockSEC:0000950170-23-028594:0
12,500 shares0Common StockSEC:0000950170-23-028595:0
12,500 shares0Common StockSEC:0000950170-23-028599:0
12,500 shares0Common StockSEC:0000950170-23-028596:0
11,249 shares@ US$3.357.5% of flowCommon StockSEC:0000950170-23-022770:0
2,368 shares@ US$3.355.3% of flowCommon StockSEC:0000950170-23-022772:0
2,807 shares@ US$3.355.5% of flowCommon StockSEC:0000950170-23-022773:0
57,950 shares0Common StockSEC:0000899243-23-009036:0
155,550 shares0Common StockSEC:0000899243-23-009035:0
62,225 shares0Common StockSEC:0000899243-23-009032:0
84 shares@ US$3.460.2% of flowCommon StockSEC:0000899243-23-005464:0
25 of 83 declarations
About Biora Therapeutics, Inc.
Biora Therapeutics, Inc. is a company in the health and pharmaceutical sector focused on developing innovative therapeutic solutions. It is listed on NASDAQ under the symbol XNAS.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
